$112.26
-0.42-0.37%
At close: Feb 13, 4:00 PM EST
$112.50
-0.18-0.16%
Pre-Market: 7:02 AM EST
Comments
Loading...
Abbott Laboratories Earnings Estimates
ABTNYSE
Abbott Laboratories Earnings Estimates, EPS & Revenue | NYSE:ABT
Abbott Laboratories (ABT) is scheduled to report Q1 earnings on April 15, 2026. Analysts estimate EPS of $1.15 and quarterly revenue of $11.01B.
In the most recent quarter (Q4), Abbott Laboratories reported EPS of $1.50, meeting estimates of $1.50. Revenue came in at $11.46B, missing the estimate of $11.80B by 0.03%.
Over the last 4 quarters, Abbott Laboratories has averaged an EPS surprise of 0.01% and a revenue surprise of 0.01%.
Earnings Date
Apr 15
EPS Estimate
$1.150
Quarterly Revenue Estimate
$11.01B
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$43.84B
Abbott Laboratories Earnings History
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Abbott Laboratories (ABT) Earnings Per Share
The chart below shows Abbott Laboratories's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-01-22 | $1.50 | $1.50 | 0.00 % |
| Q3 | 2025-10-15 | $1.30 | $1.30 | 0.00 % |
| Q2 | 2025-07-17 | $1.26 | $1.25 | 0.80 % |
| Q1 | 2025-04-16 | $1.09 | $1.07 | 1.87 % |
Abbott Laboratories (ABT) Revenue
The chart below shows Abbott Laboratories's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-01-22 | $11.46B | $11.80B | -2.87 % |
| Q3 | 2025-10-15 | $11.37B | $11.40B | -0.30 % |
| Q2 | 2025-07-17 | $11.14B | $11.04B | 0.91 % |
| Q1 | 2025-04-16 | $10.36B | $10.39B | -0.31 % |
FAQ
When is Abbott Laboratories (NYSE:ABT) reporting earnings?
Abbott Laboratories (ABT) is scheduled to report earnings on April 15, 2026. The last reported earnings were for reported on January 22, 2026 for Q4.
What were the latest earnings per share (EPS) for Abbott Laboratories (NYSE:ABT)?
The Actual EPS was $1.50, which hit the estimate of $1.50.
What were Abbott Laboratories’s (NYSE:ABT) revenues?
The Actual Revenue was $11.46B, which missed the estimate of $11.80B.
